Momelotinib Dihydrochloride Monohydrate
This page contains brief information about momelotinib dihydrochloride monohydrate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Momelotinib dihydrochloride monohydrate is approved to treat:
- Myelofibrosis (a bone marrow disease) that is intermediate risk or high risk in adults with anemia, including the following types:
Momelotinib dihydrochloride monohydrate is also being studied in the treatment of other types of cancer.
More About Momelotinib Dihydrochloride Monohydrate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Momelotinib Dihydrochloride Monohydrate - Check for trials from NCI's list of cancer clinical trials now accepting patients.